Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 019531
Company: B BRAUN
Company: B BRAUN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NUTRILIPID 10% | SOYBEAN OIL | 10% | INJECTABLE;INJECTION | Prescription | None | Yes | Yes |
NUTRILIPID 20% | SOYBEAN OIL | 20% | INJECTABLE;INJECTION | Prescription | AP | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/28/1993 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
05/17/2023 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019531s013s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/019531Orig1s013,s016ltr.pdf | |
05/17/2023 | SUPPL-13 | Manufacturing (CMC)-Manufacturing Process |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/019531Orig1s013,s016ltr.pdf |
07/14/2020 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019531s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/019531Orig1s010ltr.pdf | |
12/02/2015 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/12/2014 | SUPPL-2 | Manufacturing (CMC) |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019531s002lbl.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
05/17/2023 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019531s013s016lbl.pdf | |
07/14/2020 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019531s010lbl.pdf | |
08/12/2014 | SUPPL-2 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019531s002lbl.pdf |
NUTRILIPID 10%
There are no Therapeutic Equivalents.
NUTRILIPID 20%
INJECTABLE;INJECTION; 20%
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
INTRALIPID 20% | SOYBEAN OIL | 20% | INJECTABLE;INJECTION | Prescription | Yes | AP | 018449 | FRESENIUS |
INTRALIPID 20% | SOYBEAN OIL | 20% | INJECTABLE;INJECTION | Prescription | Yes | AP | 020248 | FRESENIUS |
NUTRILIPID 20% | SOYBEAN OIL | 20% | INJECTABLE;INJECTION | Prescription | Yes | AP | 019531 | B BRAUN |